IN2014MN01065A - - Google Patents

Info

Publication number
IN2014MN01065A
IN2014MN01065A IN1065MUN2014A IN2014MN01065A IN 2014MN01065 A IN2014MN01065 A IN 2014MN01065A IN 1065MUN2014 A IN1065MUN2014 A IN 1065MUN2014A IN 2014MN01065 A IN2014MN01065 A IN 2014MN01065A
Authority
IN
India
Prior art keywords
skin
ageing
composition
myricetin
glycoside
Prior art date
Application number
Inventor
Gail Jenkins
Silvina Beatriz Lotito
Jennifer Elizabeth Pople
Linda Jane Wainwright
Original Assignee
Unilever Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Plc filed Critical Unilever Plc
Publication of IN2014MN01065A publication Critical patent/IN2014MN01065A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Abstract

The invention relates to a skin anti ageing composition. In particular a skin anti ageing composition comprising myricetin or glycoside thereof and at least one LXR alpha agonist. By skin ageing is meant the appearance or manifestation of any one or more of wrinkles or sagging poor skin barrier such as dryness scalp itch or uneven skin tone such as age spots.
IN1065MUN2014 2011-12-06 2012-11-27 IN2014MN01065A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11192180 2011-12-06
PCT/EP2012/073697 WO2013083431A1 (en) 2011-12-06 2012-11-27 Skin anti-ageing composition

Publications (1)

Publication Number Publication Date
IN2014MN01065A true IN2014MN01065A (en) 2015-05-01

Family

ID=47226185

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1065MUN2014 IN2014MN01065A (en) 2011-12-06 2012-11-27

Country Status (9)

Country Link
US (1) US10406091B2 (en)
EP (1) EP2788088B1 (en)
CN (1) CN103957998B (en)
AU (1) AU2012348700B2 (en)
BR (1) BR112014013667A2 (en)
CA (1) CA2857231A1 (en)
IN (1) IN2014MN01065A (en)
WO (1) WO2013083431A1 (en)
ZA (1) ZA201403778B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103399151A (en) * 2013-06-24 2013-11-20 上海交通大学医学院附属瑞金医院 Application of CXCL8 cytokine detection reagent in preparation of papillary thyroid cancer diagnostic reagent
CN107106628B (en) * 2014-12-22 2021-01-12 荷兰联合利华有限公司 Hair composition
EP3397258A2 (en) * 2015-12-30 2018-11-07 Consejo Nacional De Investigaciones Cientificas Y Tecnicas (CONICET) Use of brassinosteroid analogs for the treatment of dermal disorders by selectively modulating liver x receptors (lxr) and dermal disease treatment by brassinosteroid analogs acting as selective liver x receptor (lxr) modulators
JP6353939B1 (en) * 2017-02-15 2018-07-04 横関油脂工業株式会社 Oily composition, process for producing the same, oily base and external preparation for skin
WO2018231988A2 (en) 2017-06-13 2018-12-20 Mary Kay Inc. Cosmetic compositions and methods for their use in firming skin
CN108420778A (en) * 2018-06-17 2018-08-21 佛山市芊茹化妆品有限公司 A kind of composition and its application with white-skinned face function
US20230414472A1 (en) * 2022-06-28 2023-12-28 Cosmax Inc. Cosmetic composition including garlic extract, black tea extract, and guava extract

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120805A (en) 1983-11-30 1985-06-28 Akira Kitano Skin cosmetic
FR2642305A1 (en) 1989-01-27 1990-08-03 Theramex Laboratoire Novel dermocosmetological compositions and process for obtaining them
US6414037B1 (en) 1998-01-09 2002-07-02 Pharmascience Pharmaceutical formulations of resveratrol and methods of use thereof
AT407821B (en) 1998-03-24 2001-06-25 Franz Dr Stueckler MEDIUM BASED ON NATURAL SUBSTANCES
CN1195489C (en) 1999-01-12 2005-04-06 内蒙古宇航人化妆品有限责任公司 Seabuckthorn essence concentrate
BR0010619A (en) 1999-05-17 2002-02-19 Procter & Gamble Processes to regulate and / or treat the condition of keratinous tissue and / or the skin of mammals and compositions suitable for use in regulating the condition of keratinous tissue and / or the skin of mammals
JP2001039849A (en) * 1999-07-27 2001-02-13 Shiseido Co Ltd Agent for promoting production of collagen
US6555573B2 (en) 2000-12-21 2003-04-29 The Quigley Corporation Method and composition for the topical treatment of diabetic neuropathy
FR2820975B1 (en) 2001-02-21 2004-03-12 Oreal COMPOSITION FOR TOPICAL APPLICATION COMPRISING AT LEAST ONE HYDROXYSTILBENE AND AT LEAST ONE POLYOL FOR SOLUBILIZING THE HYDROXYSTILBENE
WO2003030857A1 (en) 2001-10-04 2003-04-17 Unilever Plc Enhancing epidermal barrier development in skin
EP1314420A1 (en) * 2001-11-23 2003-05-28 Cognis Iberia, S.L. Anti-ageing composition
EP1327438A1 (en) * 2002-01-12 2003-07-16 Dr. Scheller Cosmetics AG Cosmetic composition and use of same
US6579543B1 (en) 2002-02-22 2003-06-17 Jackie H. McClung Composition for topical application to skin
EP1553851A2 (en) 2002-10-16 2005-07-20 L'oreal Cosmetic composition for preventing and/or correcting the functional disorders of the pilo-sebaceous unit of mammals
KR100600249B1 (en) * 2002-12-27 2007-04-12 주식회사한국신약 Extract of Cercis chinensis having anti-oxidant activity and anti-aging activity, and cosmetical composition containing the extract for anti-oxidation, skin-aging protection and wrinkle improvement
AU2003303370A1 (en) 2002-12-27 2004-07-22 Hankook Pharm. Co., Inc. Extract of cercis chinensis having anti-oxidant activity and anti-aging activity, and cosmetical composition containing the extract for anti-oxidation, skin-aging protection and wrinkle improvement
GB0311816D0 (en) 2003-05-22 2003-06-25 Unilever Plc Skin treatments
DE10329955A1 (en) * 2003-07-03 2005-02-03 Merck Patent Gmbh Use of a hydroalcoholic extract from bauhinia for the preparation of a preparation
US7320797B2 (en) 2003-08-29 2008-01-22 Bioderm Research Antiaging cosmetic delivery systems
US20050186171A1 (en) 2004-02-23 2005-08-25 Winick Bernyce A. Skin cream
US7455860B2 (en) 2004-08-11 2008-11-25 Laila Nutraceuticals Dietary supplement formulation for controlling inflammation and cancer
US20060078530A1 (en) 2004-10-12 2006-04-13 Liu Kay M Using high-density grapes to rejuvenate human skin
US20060110415A1 (en) 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
EP1877054A2 (en) 2005-03-30 2008-01-16 Sirtris Pharmaceuticals, Inc. Nicotinamide riboside and analogues thereof
CA2546464A1 (en) 2005-05-04 2006-11-04 Richard Wachsberg Sequential application of oral and topical formulations for treating wrinkles and other damage to skin
US20070048246A1 (en) 2005-09-01 2007-03-01 Biophysica Research, Inc. Novel skin care compositions
US20090012155A1 (en) * 2005-09-08 2009-01-08 Jeong Ki Kim Composition Of Skin External Application For Anti-Aging
CN101365431A (en) 2005-10-14 2009-02-11 帝斯曼知识产权资产管理有限公司 Novel use of nutraceutical compositions comprising resveratrol
WO2007073765A1 (en) 2005-12-28 2007-07-05 Marfarma Holding S.P.A. Methylselenol zinc salt and compositions containing it
KR101563528B1 (en) 2006-02-10 2015-10-27 마나테크, 인코포레이티드 All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization
JP4954564B2 (en) * 2006-02-10 2012-06-20 一丸ファルコス株式会社 Formulation for degrading protein-reducing sugar cross-linking substance which is Maillard reaction product
US20070225360A1 (en) 2006-03-22 2007-09-27 L'oreal Anti-aging composition containing phloretin
FR2898808B1 (en) 2006-03-27 2008-05-02 Biotechmarine Soc Par Actions "COSMETIC ACTIVE INGREDIENT COMPOSED OF ARGININE FERRULATE AND A MICROALGUE EXTRACT AND USES THEREOF".
KR20090003281A (en) 2006-03-31 2009-01-09 디에스엠 아이피 어셋츠 비.브이. Novel use of compounds and combinations of compounds for improving the physical appearance
US20100240029A1 (en) 2006-06-06 2010-09-23 Massachusetts Institute Of Technology Cholesterol-Regulating Complex of SIRT1 and LXR and Methods of Use
ITLO20060004A1 (en) 2006-08-08 2008-02-09 River Pharma Srl "LAPILLE" IS A NEW INVENTION FOR OBJECT A NEW STABLE CHEMICAL COMBINATION FOR COSMETIC AND PHARMACEUTICAL USE CONTAINING AS ACTIVE INGREDIENTS THE ALPHA-LIPOIC ACID AND DIMETHYLSULFOSID, ABLE TO IMPROVE THE ABSORPTION, THE BIO
US8435547B2 (en) 2006-08-30 2013-05-07 John P. Blass Cream for stimulating mitochondrial activity in the skin
WO2008036238A2 (en) 2006-09-19 2008-03-27 Wyeth Use of lxr modulators for the prevention and treatment of skin aging
KR100883757B1 (en) * 2007-03-12 2009-02-12 성균관대학교산학협력단 Polyphenol compounds with modulating neurotransmitter release
WO2008119070A1 (en) 2007-03-28 2008-10-02 Trustees Of Boston University Methods of treatment using sirt modulators and compositions containing sirt1 modulators
JP2008239576A (en) 2007-03-28 2008-10-09 Koei Kogyo Kk Composition containing resveratrols extracted from grape buds and vines
US7794758B2 (en) 2007-04-05 2010-09-14 Pmc Formulas, Inc. Compounds and methods for promoting cellular health and treatment of cancer
US20080254135A1 (en) 2007-04-10 2008-10-16 Marvin Heuer Resveratrol-containing compositions for general health and vitality
EP2155769B1 (en) 2007-05-04 2012-06-27 Katholieke Universiteit Leuven KU Leuven Research & Development Tissue degeneration protection
EP1992322A1 (en) 2007-05-11 2008-11-19 Dr. Scheller Cosmetics AG Composition for percutaneous application
EP2005941A3 (en) 2007-06-01 2009-04-01 Henkel AG & Co. KGaA Cellular rejuvenation compounds
WO2009003798A1 (en) 2007-07-05 2009-01-08 Unilever N.V. Food composition comprising trans-resveratrol and its use to control blood pressure
US20090028895A1 (en) 2007-07-27 2009-01-29 Smith Walter P Methods and compositions for reducing facial lines and wrinkles
US20090047309A1 (en) 2007-08-13 2009-02-19 Maes Daniel H Cosmetic methods and compositions for repairing human skin
WO2009032896A2 (en) 2007-09-08 2009-03-12 Elc Management Llc Resveratrol ferulate compounds, compositions containing the compounds, and methods of using the same
FR2923717B1 (en) 2007-11-15 2015-01-16 Caudalie COMPOSITIONS OF STILBENIC POLYPHENOLIC DERIVATIVES AND THEIR APPLICATIONS FOR COMBATING PATHOLOGIES AND ENHANCING LIVING ORGANISMS
WO2009082511A1 (en) 2007-12-20 2009-07-02 Elc Management Llc Methods and compositions for treating skin
US20110009496A1 (en) 2008-01-08 2011-01-13 Sirtris Pharmaceuticas, Inc. Resveratrol formulations
US20090324705A1 (en) 2008-02-13 2009-12-31 Nina Vikhrieva Phytonutrient compositions for topical use
US8029830B2 (en) 2008-04-18 2011-10-04 Nuvocare Health Services Inc. Composition and method for promoting internal health and external appearance
PE20091928A1 (en) 2008-05-29 2009-12-31 Bristol Myers Squibb Co HAVE HYDROXYSUSTITUTED PYRIMIDINES AS NON-BASIC MELANIN-CONCENTRATING HORMONE RECEPTOR-1 ANTAGONISTS
ES2316312B1 (en) 2008-06-20 2010-02-08 Ignacio Umbert Millet DERMATOLOGICAL PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SKIN INFLAMMATION PATHOLOGIES, SUCH AS FOR EXAMPLE DERMATITIS, ATOPICA DERMATITIS, VITILIGO, AREATA ALOPECIA, ACNE, PSORIASIS AND PRURITO, AND COMBINATIONS OF THE SAME.
JP2011526900A (en) 2008-06-30 2011-10-20 イーエルシー マネージメント エルエルシー External composition containing isonicotinamide
GB0811992D0 (en) 2008-07-01 2008-08-06 Mithen Richard Treatment
WO2010011331A2 (en) 2008-07-24 2010-01-28 The Regents Of The University Of California Compositions and methods related to sirt1 function
DE102008047362A1 (en) 2008-09-15 2010-04-15 Henkel Ag & Co. Kgaa Composition for skin lightening
MX349176B (en) 2008-09-22 2017-07-14 Biochemics Inc Transdermal drug delivery using an osmolyte and vasoactive agent.
WO2010039529A2 (en) 2008-09-23 2010-04-08 Resolvyx Pharmaceuticals, Inc. Compositions and methods for the treament of inflammatory disease
ES2349966B1 (en) 2008-10-30 2011-11-18 Ignacio Umbert Millet TOPICAL FORMULATIONS FOR THE TREATMENT OF VERRUGAS.
FR2938765B1 (en) 2008-11-26 2010-12-31 Isp Investments Inc COSMETIC AND / OR PHARMACEUTICAL COMPOSITION COMPRISING A VINE LEAF HYDROLYZATE (VITIS VINIFERA L.) AS ACTIVE INGREDIENT OF SIRT PROTEINS
WO2010090830A1 (en) 2009-01-20 2010-08-12 Isis Pharmaceuticals, Inc. Modulation of sirt1 expression
US20100215781A1 (en) 2009-02-25 2010-08-26 Joar Opheim Therapeutic composition comprising omega-3 polyunsaturated fatty acid or derivative thereof, resveratrol and green tea
JP2010202617A (en) 2009-03-05 2010-09-16 Kose Corp Singlet oxygen eliminator, and skin care preparation and cosmetic containing the same
US20100233128A1 (en) 2009-03-13 2010-09-16 Mci Media Capital Inc. Natural Skin Products Containing Dairy and Processes
FR2949044B1 (en) 2009-08-12 2021-05-07 Expanscience Lab COMPOSITION INCLUDING A FRACTION OF THE UNSAPONIFIABLE
ITMI20091940A1 (en) 2009-11-05 2011-05-06 Functional Point S R L COMPOSITION INCLUDING RESVERATROL AND AT LEAST ONE RED WINE POLYPHENOL AND ITS USES.

Also Published As

Publication number Publication date
EP2788088B1 (en) 2019-06-19
AU2012348700B2 (en) 2015-08-27
EP2788088A1 (en) 2014-10-15
ZA201403778B (en) 2015-11-25
BR112014013667A2 (en) 2017-06-13
CN103957998B (en) 2018-06-12
US20140295010A1 (en) 2014-10-02
US10406091B2 (en) 2019-09-10
CA2857231A1 (en) 2013-06-13
CN103957998A (en) 2014-07-30
AU2012348700A1 (en) 2014-06-12
WO2013083431A1 (en) 2013-06-13

Similar Documents

Publication Publication Date Title
IN2014MN01065A (en)
EP3035908A4 (en) Topical skin compositions for treating wrinkles
MX355080B (en) Improving skin appearance with increase in skin chroma.
SG11201604697TA (en) Membrane-penetrating peptides to enhance transfection and compositions and methods for using same
EP2528455A4 (en) Methods to treat mixtures of glycosides to obtain one or more of these glycosides in more pure form
MX349544B (en) Maesa japonica extracts and methods of use.
MX2017007868A (en) Compositions for providing improved sunscreen protection.
PH12015502405A1 (en) Methods and compositions for wound healing
HK1217453A1 (en) Methods and compositions for improving appearance and formation of scar tissue
IN2015DN03897A (en)
WO2012092350A3 (en) Topical uses szeto-schiller peptides
GB2541318A (en) Use of undaria extract to reduce signs of skin aging
GB2541316A (en) Compositions and methods for reducing oxidative stress
GB201901812D0 (en) Improvements in or relating to fire-rated door sets
GB2541315A (en) Topical compositions for stimulating adipogenesis and lipogenesis to reduce the signs of skin aging
EP3052117A4 (en) Methods and compositions to inhibit metastasis and to treat fibrosis and to enhance wound healing
BR112015022265B8 (en) PIGMENTED COMPOSITIONS FOR SKIN TREATMENT
BR112015022275B8 (en) PIGMENTED COMPOSITIONS FOR SKIN TREATMENT
WO2012173383A3 (en) Skin composition for external use containing cryptotanshinone as active ingredient
GB2540319A (en) Topical composition including a combination of extracts for reducing signs of skin aging
GB2541317A (en) Methods of reducing signs of skin aging
GB2541576A (en) Methods of reducing signs of skin aging using a combination of extracts
MX2016013544A (en) Use of bidens extract to reduce signs of skin aging.
WO2014004178A3 (en) Compositions comprising substituted phenols and topical application thereof
HK1217459A1 (en) Methods and compositions for improving appearance and formation of scar tissue